San Diego—Verogen Inc., the world’s first sequencing company solely dedicated to forensic science, announced today that it will begin taking orders and shipping products in the Americas (including the U.S., Canada, Mexico, Central and South America) beginning February 22, 2018 and in EMEA (Europe Middle East, Africa) and China beginning March 9, 2018. Verogen is an […]
AMSBIO is a specialist life science company offering an extensive portfolio of Poly (ADP-ribose) polymerase (PARP) isozymes. In addition, AMSBIO also offer assay kits, inhibitors, recombinant histone substrates and screening / profiling services for over 10 different PARP’s. Poly (ADP-ribose) polymerase (PARP) is a family of proteins that transfer ADP-ribose units from NAD+ onto target […]
–Joining forces for single-cell research excellence– PLEASANTON, CA.—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that it has joined the Corporate Partnership Program of the European Molecular Biology Laboratory (EMBL), one of the world’s leading research institutions. “As a leader in single cell genomics, 10x Genomics is investing in institutional training […]
CE-IVD labeled PAXgene® Blood ccfDNA tube will be available in Western Europe FRANKLIN LAKES, N.J. and EYSINS, Switzerland — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial availability of the CE-IVD marked PAXgene® Blood ccfDNA tube within the European Economic Area and Switzerland (Western Europe). The plastic blood collection tube, which includes […]
Patents in South Korea and Israel cover integration of an external DNA sequence into the chromosome of eukaryotic cells Merck continues to support research with genome editing under careful ethical and legal standards Merck to license its CRISPR-related patents to interested parties Darmstadt, Germany – Merck, a leading science and technology company and leader in genome editing, […]
InDevR has announced that it has expanded its VaxArray® product portfolio with a new reagent kit to address the “need for speed” in combating flu viruses with pandemic potential. The VaxArray Influenza Pandemic Hemagglutinin potency test kit is now available for flu vaccines containing H5, H7, and H9 flu subtypes, which includes new H7 vaccines against […]
SAN FRANCISCO, Calif. – Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the commercial availability of several new products to enhance next-generation sequencing including its Twist Human Core Exome Kit, an innovative and comprehensive library preparation and target enrichment kit, and its Custom Panels offering, that […]
Launches US headquarters for marketing and distribution of proprietary Exosome Isolation System Announces plans to introduce proprietary diagnostic and therapeutic products leveraging exosome technology FREEHOLD, NJ — Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that its majority-owned subsidiary, GenExosome Technologies Inc. (GenExosome), has formally launched its U.S. operations, with plans to […]
Merger brings together Oxford, UK and Boston, MA companies offering cutting-edge research tools Absolute Antibody Ltd., an Oxford, UK-based company with a vision to make recombinant antibody technology accessible to all, and Kerafast Inc., a Boston, MA-based company with a mission to facilitate access to unique laboratory-made reagents, today announced a merger of the two […]
Horizon out-licenses proprietary cell line and Helitron transposon gene editing technologies demonstrating Horizon’s ability to generate revenues from internally derived IP Horizon retains commercial rights over improvements to its technology platforms to develop new cell line technologies and gene delivery IP that can be licensed to customers for applications in biomanufacturing, diagnostic reference standards and […]
Pay Invoice
Latest Blogs
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
-
10x Genomics Debuts First Plate-Based Assay
November 21, 2025 3:50 pm
-
Lab Tool Companies and Share Repurchases
October 30, 2025 4:15 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
